Provenance du réseau au premier degré de Peter Stein
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Ava AG
 Ava AG Miscellaneous Commercial ServicesCommercial Services Ava AG develops and offers a fertility band that allows for birth control. It offers a bracelet that indicates days on which it is possible to become pregnant. The company was founded by Lea von Bidder, Peter Stein, Philipp Tholen and Pascal Koenig in 2014 and is headquartered in Zurich, Switzerland.
5
| Subsidiary | Miscellaneous Commercial Services | 5 |
Nomoq GmbH
 Nomoq GmbH Commercial Printing/FormsCommercial Services NOMOQ GmbH digitally prints aluminum cans for any kind of beverage with high-quality and vibrant colors. The company is based in Kirchheimbolanden, Germany. The German company provides craft breweries and beverage producers with the ability to print as many cans as they want, with no minimum order quantity. NOMOQ's mission is to serve a creative community of craft drink producers and unlock their creativity with finely printed aluminum cans without minimum order quantities. NOMOQ was founded in 2021 by Peter Stein, Albrecht Haake, Gabriela Andrei, and Patrick Schweizer, with Peter Stein serving as the CEO since 2021.
3
| Holding Company | Commercial Printing/Forms | 3 |
NOMOQ AG
 NOMOQ AG Commercial Printing/FormsCommercial Services NOMOQ AG provides printing services for beverage cans. The private company is based in Zurich, Switzerland. The Swiss company was founded by Peter Stein and Patrick Schweizer, with Peter Stein serving as CEO since incorporation.
1
| Private Company | Commercial Printing/Forms | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Peter Stein via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Generic | Chairman | |
| Université Catholique de Louvain | College/University | Doctorate Degree | |
| OBSEVA SA | Pharmaceuticals: Major | Founder | |
| IPSEN | Pharmaceuticals: Major | Corporate Officer/Principal | |
Privilège Ventures SA
 Privilège Ventures SA Investment ManagersFinance Privilège Ventures SA (Privilège Ventures) is a venture capital subsidiary of Privilège Management SA founded in 2016 by Jacqueline Ruedin Rüsch. The firm is headquartered in Lugano, Switzerland. | Investment Managers | Private Equity Investor |
Statistiques
Internationale
| Suisse | 6 |
| Belgique | 2 |
| France | 2 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 2 |
| Finance | 2 |
Opérationnelle
| Founder | 9 |
| Chief Executive Officer | 4 |
| Corporate Officer/Principal | 4 |
| Chairman | 3 |
| Director/Board Member | 3 |
Relations les plus connectées
- Bourse
- Insiders
- Peter Stein
- Connexions Sociétés
